Suchergebnisse - "Hosoi, Hiroki"

PubPharm (12)

1

An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma : A multicenter retrospective cohort study

enthalten in: Journal of geriatric oncology | 2023

von Hiroi, T. | Hosoi, H. | Kuriyama, K. | +6

2

Consistently low levels of histidine-rich glycoprotein as a new prognostic biomarker for sepsis : A multicenter prospective observational study

enthalten in: PloS one | 2023

von Kawanoue, N. | Kuroda, K. | Yasuda, H. | +7

3

Successful combination treatment with rituximab, steroid pulse therapy, plasma exchange and romiplostim for very severe TAFRO syndrome

enthalten in: Leukemia & lymphoma | 2022

von Sakaki, A. | Hosoi, H. | Kosako, H. | +7

4

Prolonged Epstein-Barr virus reactivation coincident with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

enthalten in: Leukemia & lymphoma | 2022

von Hosoi, H. | Matsuyama, Y. | Murata, S. | +2

5

Longitudinal effects of a nationwide lifestyle intervention program on cardiometabolic outcomes in Japan : An observational cohort study

enthalten in: Preventive medicine | 2020

von Takeuchi, Y. | Kashiwabara, K. | Hosoi, H. | +2

6

ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia

enthalten in: Haematologica | 2020

von Zhou, J. | Yiying Quah, J. | Ng, Y. | +11

CommentIn: Haematologica. 2020 Jun 05;105(9):2191-2193. - PMID 33054042

7

Soluble NKG2D Ligands Are Potential Biomarkers and Sentinels of Immune-Mediated Bone Marrow Injury in Bone Marrow Failure Syndromes

enthalten in: Acta haematologica | 2020

von Murata, S. | Mushino, T. | Hosoi, H. | +8

8

An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome

enthalten in: Leukemia research | 2017

von Hosoi, H. | Imadome, K. | Tamura, S. | +12

9

Extracorporeal antimicrobial elimination enables antimicrobial mixing and affects resident bacteria

enthalten in: The Journal of antimicrobial chemotherapy | 2016

von Murata, S. | Mushino, T. | Hosoi, H. | +5

10

Real-time monitoring of antimicrobial use density to reduce antimicrobial resistance through the promotion of antimicrobial heterogeneity in a haematology/oncology unit

enthalten in: The Journal of antimicrobial chemotherapy | 2015

von Murata, S. | Mushino, T. | Hosoi, H. | +7